New Alzheimer's research out of ETH Zurich highlights GRK2 as a previously underappreciated driver of neurodegeneration. In mouse studies, an experimental compound, 'Compound 10,' successfully interrupted this process, reducing nerve cell loss.
Researchers at ETH Zurich have identified a previously underappreciated protein called GRK2 as a new driver of neurodegeneration in Alzheimer's disease. They developed an experimental compound, "Compo
